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Abstract
Background: Anti-N-methyl-D-aspartate receptor encephalitis is a severe autoimmune disorder characterized by severe
psychiatric symptoms, seizures, decreased consciousness, autonomic dysregulation, and dyskinesias. Multifocal subcortical
white matter lesions on fluid-attenuated inversion recovery and diffuse weighted images have rarely been reported in
previous literature, and serial magnetic resonance imaging changes after plasma exchange have not been presented before.
Case presentation: A previously healthy 24-year-old Chinese woman presented with acute psychiatric symptoms
characterized by fear and agitation followed by decreased consciousness, dyskinesias, and seizures. Magnetic resonance
imaging revealed hyperintense lesions on fluid-attenuated inversion recovery and diffuse weighted images in bilateral
subcortical white matter. Cerebrospinal fluid analysis revealed a mild pleocytosis with lymphocytic predominance.
Protein and glucose levels were normal. Aquaporin-4 antibodies in serum and cerebrospinal fluid were negative. Identification
of anti-N-methyl-D-aspartate receptor antibodies in serum and cerebrospinal fluid confirmed the diagnosis of
anti-N-methyl-D-aspartate receptor encephalitis. She was initially treated with combined intravenous immunoglobulin
and methylprednisolone without improvement. Plasma exchange was then initiated with good response; the patient
made a full recovery after several cycles of plasma exchange. Repeat magnetic resonance imaging performed 1 month
after plasma exchange showed partial resolution of the hyperintense lesions in bilateral subcortical white matter, and
follow-up magnetic resonance imaging 2 months after plasma exchange showed complete resolution.
Conclusion: Anti-N-methyl-D-aspartate receptor encephalitis may be concomitant with multifocal subcortical white
matter lesions. Such lesions may resolve after appropriate immunotherapy.
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Background
Anti-N-methyl-D-aspartate (NMDA) receptor encephal-
itis is a severe autoimmune disorder first described by
Dalmau and his colleagues in 2007 [1]. Patients with anti-
NMDA receptor encephalitis usually have an acute onset.
The typical clinical features include severe psychiatric
symptoms, memory loss, seizures, decreased conscious-
ness, autonomic dysregulation, and dyskinesias [2].
Here, we describe a case of anti-NMDA receptor en-
cephalitis with multifocal subcortical white matter le-
sions on fluid-attenuated inversion recovery (FLAIR)
and diffuse weighted images (DWI). This patient
responded well to plasma exchange treatment. Serial
magnetic resonance imaging (MRI) changes after this
treatment are presented. To our knowledge, multifocal
subcortical white matter lesions on FLAIR and DWI
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have rarely been described in previous literature, and
serial MRI changes after plasma exchange have not been
presented before.
Case presentation
A 24-year-old Chinese woman presented with acute psy-
chiatric symptoms characterized by fear and agitation.
Two days after symptom onset, she was admitted to a
psychiatric hospital, and her symptoms were temporarily
controlled. Seven days after symptom onset, she devel-
oped a low-grade fever and decreased consciousness, at
which point she was transferred to our hospital. Her
past medical history was unremarkable. On examination,
she was non-responsive to verbal or painful stimulation.
Her vital signs indicated slightly elevated heart rate and
body temperature and normal blood pressure and re-
spiratory rate. The pupils were normal in size and react-
ive to light. Spontaneous eye movements were absent.
The oculocephalic responses were present. Babinski’s
sign was negative bilaterally, and both Kernig’s and
Brudzinski’s signs were negative.
Routine blood test and chemistry analysis including
liver, renal, and thyroid function were unremarkable.
The erythrocyte sedimentation rate was normal. Auto-
immune markers including antinuclear antibodies,
anti-double-stranded DNA (anti-dsDNA) antibodies,
rheumatoid factor, and antineutrophilcytoplasmic anti-
bodies (ANCA) were negative. Serum anti-thyroglobulin
(anti-TG) antibodies (38.4U/ml, normal range 0–60 U/ml,
radioimmunoassay) and anti-thyroid peroxidase (anti-
TPO) antibodies (28 U/ml, normal range 0–60 U/ml,
radioimmunoassay) were unremarkable. Brain computed
tomography (CT) was normal. MRI revealed FLAIR and
DWI hyperintense lesions in bilateral subcortical white
matter (Fig. 1a,b). Electroencephalography (EEG) showed
diffuse slow-waves. Cerebrospinal fluid (CSF) analysis re-
vealed a mild pleocytosis (24 × 106/L) with lymphocytic
predominance. Protein and glucose levels were normal.
Aquaporin-4 antibodies in serum and CSF were negative.
Serological and polymerase chain reaction (PCR) investi-
gation in serum and CSF were negative for infectious eti-
ologies including varicella zoster virus, enterovirus, herpes
simplex virus, cytomegalovirus, and Epstein-Barr virus.
Bacterial cultures of the CSF were negative. Anti-NMDA
receptor antibodies were identified both in serum (titers
1:100) and CSF (titers 1:16).
The diagnosis of anti-NMDA receptor encephalitis
was established. Thorough evaluation, including ovarian
ultrasound and high resolution computed tomography
of the chest, abdomen, and pelvis, did not reveal an
ovarian teratoma or other tumors. Intravenous immuno-
globulin (IVIg, 0.4 g/kg/day for 5 days) combined with
high dose methylprednisolone (1g/day for 5 days) was
initiated on day 18 after symptom onset. Despite IVIg
and steroid therapy, the patient’s level of consciousness
did not improve. She developed dyskinesias with mouth
chewing, tongue thrusting, and twisting of the upper
limbs. Episodes of generalized tonic-clonic convulsions
were also seen. Repeat EEG again revealed diffuse slow-
waves. At this point, the patient was intubated and
mechanically ventilated. Valproic acid and intermittent
intravenous diazepam was administered to control the
seizures. On day 35, plasma exchange therapy was initi-
ated; the patient regained consciousness after two cycles
of plasma exchange, and seizures and dyskinesias were
controlled after three cycles of this treatment. An
additional four cycles of plasma exchange were given to
reinforce the efficacy. Repeat MRI performed 1 month
after plasma exchange showed partial resolution of the
hyperintense lesions in bilateral subcortical white matter
on FLAIR and DWI (Fig. 1c,d). MRI performed 2
months after plasma exchange showed complete reso-
lution (Fig. 1e,f ). Repeat CSF analysis revealed normal
leucocytes (2 × 106/L), as well as normal protein and
glucose levels. Anti-NMDA receptor antibodies were
undetectable in serum and CSF. At 12-months follow-
up, the patient remained well and has had no relapse of
seizures and dyskinesias.
Fig. 1 Serial MRI findings: hyperintense lesions on FLAIR and DWI in
bilateral subcortical white matter before plasma exchange (a, b);
partial resolution of the lesions on FLAIR and DWI 1 month after
plasma exchange (c, d); full resolution of the lesions on FLAIR and
DWI 2 months after plasma exchange (e, f)
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Discussion
Our patient presented with acute psychiatric symptoms,
followed by low-grade fever, decreased consciousness,
dyskinesias, and seizures. This case demonstrates the
classic clinical presentation of anti-NMDA receptor en-
cephalitis. Identification of anti-NMDA receptor anti-
bodies in serum and CSF confirmed the diagnosis.
In recent years, autoimmune etiologies of encephalitis
are increasingly being recognized. Anti-NMDA receptor
encephalitis has been regarded as the second most
common immune-mediated cause, after acute dissemi-
nated encephalomyelitis, and is more prevalent than all
antibody-associated encephalitis. This disease is a highly
characteristic and recognizable neuropsychiatric syn-
drome, although atypical cases may exist [3–5]. It is
most common in young women and children. Over half
of the patients have an associated tumor, most com-
monly an ovarian teratoma [2].
Brain MRI in patients with anti-NMDA receptor
encephalitis may be either normal or abnormal. The fre-
quency of abnormal brain MRI is not as common as in
infectious encephalitis such as herpes simplex encephal-
itis (HSE). It has previously been described that more
than 90% of patients with HSE have MRI abnormalities,
usually in the temporal lobe, frontobasal, and insular re-
gions [6]. In a clinical-radiological comparison between
herpetic encephalitis and limbic encephalitis of auto-
immune etiologies (including anti-NMDA receptor en-
cephalitis), MRI was abnormal in all cases of the former,
but only in 60% of the latter [7].
In a cohort of 100 patients with anti-NMDA receptor
encephalitis, brain MRI was unremarkable in 45 patients;
in the other patients, T2 or FLAIR signal hyperintensity
was seen in the hippocampi, cerebellar or cerebral cor-
tex, frontobasal and insular regions, basal ganglia, and
brainstem [8]. In another cohort of 44 patients, only 4
patients had abnormalities in the hippocampi, and 6
patients had abnormalities within white matter regions
on T2/FLAIR [9].
The initial MRI of our case showed hyperintense le-
sions in bilateral subcortical white matter on FLAIR and
DWI. FLAIR combined with DWI is more sensitive in
detecting abnormalities than conventional MRI sequences.
DWI has long been established as a routine imaging pro-
cedure in acute ischemic stroke. It is exquisitely sensitive
in demonstrating even minute acute ischemic lesions [10].
It is now also used to diagnose other disorders including
limbic system encephalitis. To our knowledge, multifocal
subcortical white matter lesions on FLAIR and DWI have
rarely been reported in previous literature, and serial MRI
changes after plasma exchange have not been presented
before. The clinical presentation of our patient, however,
seemed unrelated to the lesions seen on FLAIR and
DWI. Such abnormalities on MRI resemble that of
demyelinating diseases such as acute disseminated
encephalomyelitis, neuromyelitis optica, or multiple
sclerosis. This may reflect autoimmune-mediated
white matter disease. Literature suggests that anti-
NMDA receptor encephalitis may have overlapping
characteristics with other autoimmune diseases. For
example, Zoccarato et al. described a case of anti-
NMDA receptor encephalitis followed by neuromyeli-
tis optica [11]. The coexistence of multiple auto-
immune diseases is increasingly recognized among
autoantibody-associated neurological syndromes [12].
The treatment of anti-NMDA receptor encephalitis in-
cludes immunotherapy and tumor removal, if applicable.
As of yet, no randomized trials have been performed to
evaluate the efficacy of immunotherapy. In a cohort of
577 patients (501 assessable), 472 underwent first-line
immunotherapy (steroids, IVIg, or plasma exchange) or
tumor removal, resulting in improvement within 4
weeks in 251 patients. Of the 221 patients who did not
improve with first-line treatment, 125 received second-
line immunotherapy (rituximab or cyclophosphamide),
which resulted in a better outcome. Predictors of good
outcome were early treatment and no admission to an
intensive care unit [13]. For immunotherapy of anti-
NMDA receptor encephalitis, Dalmau et al. prefer
concurrent IVIg and methylprednisolone to plasma ex-
change because plasma exchange is more difficult to do
in children, poorly cooperative patients, or patients with
autonomic instability. If no response is seen after 10
days, second-line therapy should be initiated [14]. Other
methods of immunotherapy have also been reported on
rare occasions. Liba et al. described an 8-year old girl
with anti-NMDA receptor encephalitis who had no re-
sponse to sequential IVIg, plasma exchange and high-
dose corticosteroids, rituximab, and cyclophosphamide
treatment, but responded well to alemtuzumab, an anti-
CD52 monoclonal antibody that affects memory B cells
and T cells [15].
Our patient was initially treated with combined IVIg
and methylprednisolone without demonstrable improve-
ment. However, she responded well after plasma ex-
change was initiated. After several cycles of plasma
exchange, she made a full recovery. Repeat detection of
anti-NMDA receptor antibodies in serum and CSF were
negative, and repeat MRI performed 1 month and 2
months after plasma exchange showed gradual reso-
lution of the lesions.
Conclusions
We describe a case of anti-NMDA receptor encephalitis
concomitant with multifocal subcortical white matter
lesions on FLAIR and DWI. This patient responded well
to plasma exchange treatment, after which the lesions
resolved.
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